SPDR S&P Biotech ETF
131 hedge funds and large institutions have $1.62B invested in SPDR S&P Biotech ETF in 2014 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 45 increasing their positions, 46 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
26.63% more ownership
Funds ownership: 360.81% → 387.44% (+27%)
7% more funds holding
Funds holding: 122 → 131 (+9)
2% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 46
Holders
131
Holding in Top 10
4
Calls
$142M
Puts
$89.2M
Top Buyers
| 1 | +$95.7M | |
| 2 | +$73.4M | |
| 3 | +$59.5M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$44.1M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$16M |
Top Sellers
| 1 | -$15.9M | |
| 2 | -$12.3M | |
| 3 | -$6.01M | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$4.4M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$4.31M |